RxDoctor Payments Data

Damika Harmon

Adult Health · Lake Charles, LANPI 1134356462

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 93.1% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $13,183, more than ten times the $546 reported in 2021. Among adult health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,964in general payments, 2019–2025

Across 136 payments — averaging $198.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$25K
  • Viiv Healthcare Company$575
  • AbbVie$254
  • Teva Pharmaceuticals USA, Inc.$227
  • Merck$131
  • AstraZeneca$130
  • plus $535 from 7 others

What the payments were for

  • Consulting fees$1,3205%
  • Speaking & faculty fees$13,59050%
  • Travel & lodging$7,34427%
  • Food & beverage$4,58117%
  • Education$1280%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,964 in reported general payments places this provider in the 95th percentile of 203 adult health providers in Louisiana.

See all adult health providers in Louisiana

Other adult health in Lake Charles

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →